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Background In recent years, subcutaneous implantable cardioverter-defibrillator (S-ICD) implants have progressively increased
and have been shown to be safe and highly successful, affording low reintervention rates regardless of the tech-
nique used.
...................................................................................................................................................................................................
Case summary We present a case of S-ICD implantation in a patient diagnosed with idiopathic ventricular fibrillation. In the first
follow-up consultation the patient showed appropriate detection parameters in the three configurations. However,
chest X-ray revealed lead displacement with a tip migration from the manubrium area of the sternum to the xiph-
oid process.
...................................................................................................................................................................................................
Discussion This case highlights the importance of performing at least one chest X-ray during the first weeks after S-ICD im-
plantation, allowing the detection of a problem such as lead displacement, which can lead to undersensing of ven-
tricular arrhythmias or S-ICD oversensing.
                                                                                                                                                                                                                   
Keywords Cardiac devices • S-ICD • X-ray • Case report
Introduction
Subcutaneous implantable cardioverter-defibrillators (S-ICDs) are
alternatives to transvenous implantable cardioverter-defibrillators
(ICDs) for preventing sudden cardiac death in patients who do not
require bradycardia or antitachycardia pacing.1 These devices were
developed to eliminate the primary risks of transvenous ICDs, such
as lead dysfunction or device infection, both associated with
increased morbi-mortality.2,3
Learning points
• Lead dislodgement after subcutaneous implantable cardi-
overter-defibrillator (S-ICD) implantation is a rare
complication.
• Routine device checks may be not sufficient to ensure ad-
equate S-ICD performance.
• A chest X-ray within the first weeks after implantation is
needed to assess correct lead position and complement device
revision.
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..The S-ICD implant procedure has been shown to be safe and the
implant success rate high, accompanied by low reintervention rates
regardless the technique used.4,5 In addition, the design of high-pass
filters (SMARTpass filtering) has drastically reduced T-wave
oversensing.6
Timeline
Case presentation
A 29-year-old man with no previous history of cardiovascular disease
(weight 76 kg; height 177 cm; body mass index 24) presented with
out-of-hospital cardiac arrest. The rhythm initially recorded was ven-
tricular fibrillation. He was admitted to another centre where a com-
plete cardiac study (echocardiogram, cardiac magnetic resonance,
ajmaline test, and coronary angiography) was performed. The specific
cause of cardiac arrest was not identified. According to European
Society of Cardiology (ESC) guidelines, implantable cardioverter-
defibrillator (ICD) implantation is recommended for survivors of
idiopathic ventricular fibrillation (Class of recommendation I; Level of
evidence B)1; therefore, an S-ICD (EMBLEM; Boston Scientific) was
implanted using the two-incision technique. The secondary vector
(distal-tip-to-can) was the chosen configuration, and the SMARTPass
sensing filter was also activated. The patient was discharged and
referred to our centre 13days later for device and clinical follow-up.
At this 13-day follow-up, no clinical complications were revealed.
Assessment of the S-ICD electrograms revealed unremarkable
results (Figure 1). Neither arrhythmias nor oversensing episodes
were identified, and the secondary vector continued as the configur-
ation of choice to obtain adequate signal amplitude. The SMARTPass
filter remained activated (Figure 2).
According to our institutional protocol, a chest X-ray was per-
formed, which surprisingly revealed an important inferior lead dis-
placement (by about 9 cm). This lead dislodgement had not been
previously detected during device interrogation, because the distal
electrode moved to the proximal electrode position, so the detec-
tion of the device remained unchanged (Figure 3).
The heart did not interpose between the coil and the ICD gener-
ator; therefore, the lead was replaced. During reintervention, an S-
ICD lead was found to be stitched without sufficient firmness at the
xiphoid level, allowing displacement of the distal electrode 2 cm
above the xiphoid appendage. To reduce the risk of displacement of
the new lead, the three-incision technique was performed, fixing the
lead tip to the underlying fascia and muscle at the manubriosternal
junction, 1 cm left of the midline. Further dislodgement was not sub-
sequently observed (Figure 4).
Discussion
This case shows that S-ICD lead displacement can occur without de-
tection by remote device monitoring (Latitude) or routine device re-
vision. This should be kept in mind because important lead
displacement can have important repercussions in the treatment of
ventricular arrhythmias. Proper functioning of the S-ICD is directly
related to the position of its components (device-electrode) in the
thorax and their relationships with the heart in the presence of malig-
nant arrhythmias.
The displacement of an S-ICD lead is a rare complication (0.8–
1.7%), and its primary aetiology is inadequate fixation of the suture
olive in the muscular plane. This migration usually manifests itself by
producing inappropriate discharges as a result of extracardiac detec-
tion signals. Three circumstances necessitate intraoperative S-ICD
lead repositioning: (i) when the defibrillation threshold is not met
(failure of a defibrillation test); (ii) when sensing fails in the three vec-
tors; and (iii) when the myocardium does not interpose between the
coil and the generator.7–10
.................................................................................................
Day Hour Event
0 Subcutaneous implantable cardioverter-defibrillator
(S-ICD) implant after aborted sudden death and
normal cardiovascular studies.
13 10:30 First follow-up consultation and detection of elec-
trode displacement.
16 08:30 Reintervention for S-ICD implant with the three
incisions technique.
17 10:00 Device and X-ray control, patient discharge.
45 10:00 Follow-up consultation demonstrating normal func-
tioning of the S-ICD.
Figure 1 Subcutaneous electrocardiogram detected by the device at first follow-up.
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Figure 2 Thirteen days post-implant. Device interrogation does not show alerts; the SMARTPass is activated.
Figure 3 Posteroanterior and lateral chest X-ray showing lead displacement from its original position (red arrow) to the lower parasternal region
(black arrows).
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In this case, the secondary configuration (tip-electrode-to-can)
likely acted as a primary configuration (proximal-electrode-to-can),
given that the distal electrode of the lead was placed where the prox-
imal electrode had previously been. The excellent signal obtained in
both positions did not produce inappropriate shocks, and the
SMARTPass filter remained activated. However, in ventricular ar-
rhythmia, the shock could have been ineffective, given that the coil
was in a low position, thus excluding the cardiac structure between it
and the can.
Since its initial description, the two-incision technique has been
shown to provide technical and aesthetic advantages over the three-
incision technique (Table 1)11; however, it has not been shown to re-
duce the frequency of electrode displacement.2 In our case, the
three-incision technique was chosen at reintervention to provide
greater distal support to the electrode.
In the S-ICD System IDE Clinical Investigation, device interroga-
tions and chest X-rays were performed at hospital discharge and at
30, 90, and 180 days after implantation.13 However, in other studies
performed in a real-world setting, no information about performing
chest X-rays during follow-up was provided.2,4,12,13 Our protocol
specifies two X-rays during follow-up (at 4weeks and again between
the 6th and 12th months).
Conclusions
This case highlights the importance of performing at least one chest
X-ray during the first weeks after implantation of an S-ICD, allowing
detection of a problem such as lead displacement, which can lead to
undersensing ventricular arrhythmias or S-ICD oversensing. Real-
world, multicentre registries are needed to better explore the causes
and best management of S-ICD complications.
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Figure 4 Position of the subcutaneous implantable cardioverter-defibrillator electrode after the three-incision technique.
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Table 1 Comparison between S-ICD implant
techniques
Advantages Disadvantages
Two
incisions
• Shorter procedure
time.
• Greater comfort; aes-
thetically superior.
• Poor distal lead
support.
Three
incisions
• Distal lead support. • Longer procedure
time.
• The high sternal
wound is associated
with superficial infec-
tions and discomfort.
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